270 related articles for article (PubMed ID: 12228845)
1. The practical aspects of combination therapy with angiotensin receptor blockers and angiotensin-converting enzyme inhibitors.
Sica DA
J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):66-71. PubMed ID: 12228845
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
Ghanem FA; Movahed A
Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
[TBL] [Abstract][Full Text] [Related]
4. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
5. Combination therapy with ACE inhibitors and angiotensin-receptor blockers in heart failure.
Scow DT; Smith EG; Shaughnessy AF
Am Fam Physician; 2003 Nov; 68(9):1795-8. PubMed ID: 14620599
[TBL] [Abstract][Full Text] [Related]
6. Managing hypertension using combination therapy.
Frank J
Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics and pharmacodynamics of angiotensin-receptor blockers in end-stage renal disease.
Sica DA; Gehr TW
J Renin Angiotensin Aldosterone Syst; 2002 Dec; 3(4):247-54. PubMed ID: 12584668
[TBL] [Abstract][Full Text] [Related]
10. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Weber MA
Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
[TBL] [Abstract][Full Text] [Related]
11. Progress in the development of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Singh RK; Barker S
Curr Opin Investig Drugs; 2005 Mar; 6(3):269-74. PubMed ID: 15816503
[TBL] [Abstract][Full Text] [Related]
12. Combining renin-angiotensin-aldosterone system blockade with diuretic therapy for treatment of hypertension.
Motwani JG
J Renin Angiotensin Aldosterone Syst; 2002 Jun; 3(2):72-8. PubMed ID: 12228846
[TBL] [Abstract][Full Text] [Related]
13. [Antihypertensive therapy using a combination of angiotensin-1 receptor inhibitors and angiotensin-converting enzyme inhibitors].
Schute L
Dtsch Med Wochenschr; 1998 Oct; 123(43):1295. PubMed ID: 9818002
[No Abstract] [Full Text] [Related]
14. Are angiotensin-receptor blockers (ARBs) equivalent to or better than angiotensin-converting enzyme (ACE) inhibitors in the treatment of heart failure?
Reigle J
Crit Care Nurse; 2004 Dec; 24(6):67-9. PubMed ID: 15646090
[No Abstract] [Full Text] [Related]
15. A hard look at angiotensin receptor blockers in heart failure.
Gring CN; Francis GS
J Am Coll Cardiol; 2004 Nov; 44(9):1841-6. PubMed ID: 15519017
[TBL] [Abstract][Full Text] [Related]
16. [Standpoint on the use of angiotensin receptor blockers in the treatment of hypertension].
Stern N; Grossman E; ; ; ;
Harefuah; 2003 Apr; 142(4):309-11, 315. PubMed ID: 12754885
[TBL] [Abstract][Full Text] [Related]
17. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
Zaffanello M; Franchini M; Fanos V
Pharmacotherapy; 2008 Jan; 28(1):125-30. PubMed ID: 18154482
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in hypertension due to primary aldosteronism: a case for exclusion.
Bubbar CD; Blackburn DF; Wilson MP; Wilson TW
Ann Pharmacother; 2007 Jan; 41(1):129-32. PubMed ID: 17179189
[TBL] [Abstract][Full Text] [Related]
19. Renin-angiotensin-aldosterone system blockade and renal protection: angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers?
Ruilope LM
Acta Diabetol; 2005 Apr; 42 Suppl 1():S33-41. PubMed ID: 15868118
[TBL] [Abstract][Full Text] [Related]
20. [Combination therapy with angiotensin receptor blockers and ACE inhibitors - pro].
Zidek W
Dtsch Med Wochenschr; 2009 Nov; 134(45):2294. PubMed ID: 19876805
[No Abstract] [Full Text] [Related]
[Next] [New Search]
